The researchers used EHRs from more than 4,000 adult patients admitted to five Mount Sinai hospitals from March to May to develop the predictive models. Patient data analyzed included medical history, comorbidities, vital signs and lab results to predict critical events such as intubation and mortality.
Using the models, the researchers were able to predict a critical event or mortality at time windows of three, five, seven and 10 days from admission. The one-week mark performed best overall and correctly flagged the most critical events while simultaneously producing the fewest false positives.
“… We have created a method that identifies important health markers that drive likelihood estimates for acute care prognosis and can be used by health institutions across the world to improve care decisions, at both the physician and hospital level, and more effectively manage patients with COVID-19,” said Girish Nadkarni, MD, clinical director of Mount Sinai’s digital health institute, according to the Nov. 11 news release.
More articles on artificial intelligence:
Amgen, Japanese drugmaker join study using AI to improve COVID-19 treatment protocols
Google launches AI tools for healthcare to streamline document review, analysis
6 recent studies exploring AI in healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
